Skip to content
Screener

PP&E (Net) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$10.76B+11.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.49B-7.0%
eXoZymes, Inc. logo
eXoZymes, Inc.EXOZ
$747.86K-11.3%
TEC
Bio-TechneTECH
$232.99M-7.5%
Revvity logo
RevvityRVTY
$456.25M-8.6%
Sana Biotechnology logo
Sana BiotechnologySANA
$25.67M-65.2%

Other financials

Income statement

See full
Revenue$20.2M-48.5%
Gross profit$18.4M-45.4%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$520.64M-26.8%
Enterprise value$752.73M-15.2%
P/S4.7×+1.3×

Profitability

See full
Gross margin91.8%
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity+0.3×
Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054298
Line itemAs of June 30, 2026As of December 31, 2025
Prepaid expenses and other current assets (includes $4,444 and zero from related parties)17,35924,963
Total current assets332,535471,838
Restricted cash and cash equivalents, non-current84,56538,138
Property, plant and equipment, net157,185167,371
Operating lease right-of-use assets347,661360,918
Investments14,77515,066
Equity method investments7,615
Intangible assets, net44,38753,482

Item 1. Financial Statements (Unaudited)

FAQ

What is Ginkgo Bioworks's PP&E (net)?
Ginkgo Bioworks (DNA) reported PP&E (net) of $157.19M in Q2 2026.
How has Ginkgo Bioworks's PP&E (net) changed year-over-year?
Ginkgo Bioworks's PP&E (net) decreased by 15.7% year-over-year, from $186.35M to $157.19M.
What is the long-term trend for Ginkgo Bioworks's PP&E (net)?
Over 5 years (2020 to 2025), Ginkgo Bioworks's PP&E (net) has grown at a 6.6% compound annual growth rate (CAGR), from $121.44M to $167.37M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Ginkgo Bioworks's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude